公司資料
Johnson & Johnson 股價、新聞與催化劑
- 股票代碼:
- JNJ
- 交易所:
- NYSE
- 產業:
- Biopharma, Small Molecule Drugs, Nucleic Acid Drugs, Novel Therapies
- 所在地:
- United States
股票表現
273.04 USD (+1.04%)
收盤價
最後更新: 2026年8月24日
537B USD
市值
股價為何變動
As of Aug 24, 2026, JNJ closed up 1.04% at $273.04. No new same-company headline was identified in the current news window.
公司概覽
業務概覽
Johnson & Johnson is a global healthcare leader spanning innovative medicines and medtech. Its scale, diversification, and broad therapeutic reach make it one of the most important names in the sector.
所在地與產業分類
Headquartered in the United States and listed on NYSE, J&J has a global footprint across pharmaceuticals and medical devices. It is a diversified healthcare company rather than a pure biotech or single-segment platform.
商業模式特徵
The company generates value through product sales across medicines, surgery, orthopedics, and medtech franchises. Investors focus on pipeline depth, launch execution, and the ability to replace mature products with new growth drivers.
生技產業定位
J&J sits above the biotech cycle as a diversified healthcare bellwether. It is less volatile than development-stage biotech, but regulatory and pipeline updates still matter because they shape long-term growth expectations.
未來催化劑
- Johnson & Johnson’s near-term watchpoints are the TAR-210 uro-oncology program, RYBREVANT FASPRO rollout, and any further updates that show whether the company can keep turning new assets into commercial momentum. The key question is whether the update shows enough repeatable demand to look like a durable revenue driver rather than a one-quarter bump. If adoption broadens, sentiment can improve faster than the reported numbers alone would suggest.
近期新聞
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。